| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.09 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.29 | 0.1 |